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EMPIRICAL PAPER
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Abstract
Background: Systematic studies of the efficacy of Narrative Therapy (NT) for depression are sparse.Objective: To evaluate
the efficacy of individual NT for moderate depression in adults compared to Cognitive-Behavioral Therapy (CBT).Method:
Sixty-three depressed clients were assigned to either NT or CBT. The Beck Depression Inventory-II (BDI-II) and Outcome
Questionnaire-45.2 (OQ-45.2) were used as outcome measures. Results: We found a significant symptomatic reduction in
both treatments. Group differences favoring CBT were found on the BDI-II, but not on the OQ-45.2. Conclusions: Pre- to
post-treatment effect sizes for completers in both groups were superior to benchmarked waiting-list control groups.
Keywords: depression; treatment of depression; psychological treatment of depression; Empirically Supported Therapy
(EST); Narrative Therapy; Cognitive-Behavioral Therapy
Depression is among themost commonmental health
problems for which help is sought (Andrews &
Thomson, 2009; Roness, Mykletun, & Dahl, 2005).
Despite the fact that 12 treatments for unipolar
depression are currently listed as having reliable
empirical support (for a complete list, see Hayes and
Strunk, n.d.), a considerable proportion of clients
leave treatment without substantial gains and/or
relapse after treatment. Thus, outcome research
with an emphasis on treatment efficacy is recom-
mended (Chambless & Hollon, 1998; Chambless
et al., 1998; Kendall, 1998; Kendall, Holmbeck, &
Verduin, 2004).
Narrative Therapy (NT; White, 2007; White &
Epston, 1990) is a psychotherapeutic approach
based on the notion that people construct narra-
tives to define themselves and give meaning to
their daily experiences and life events. Psycholo-
gical suffering is viewed as a problem-saturated
way of constructing life stories and a person’s
identity. These rigid self-narratives constrain the
person’s actions, feelings, and thoughts (White,
2007) and obscure life alternatives. The purpose of
psychotherapy is to help clients narrate their life
stories in richer and more gratifying ways. This
view of the human being as a meaning-making
agent has had a considerable impact on clinical
psychology and psychotherapy in recent years
(Angus & McLeod, 2004).
Although widely practiced throughout the world,
NT remains underresearched (Busch, 2011; Che-
nail, DeVicentis, Kiviat, & Somers, 2012; Etchison &
Kleist, 2000). Some qualitative process research
studies (Matos, Santos, Gonçalves, & Martins, 2009;
Moreira, Beutler, & Gonçalves, 2008) and several
case studies (Betchley & Falconer, 2002; Cashin,
2008; da Costa, Nelson, Rudes, & Guterman, 2007;
Draucker, 1998; Kropf & Tandy, 1998; Nylund,
2002; Palgi & Ben-Ezra, 2010; Rothschild, Brownlee,
& Gallant, 2000; Young, 2008) suggest positive out-
comes for a wide range of problems and disorders.
However, only one of these qualitative studies
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(Kropf & Tandy, 1998) has addressed the effective-
ness of NT for depression, and none have done so in a
controlled clinical trial. To the best of our knowledge,
only one study tested the efficacy of NT (White &
Epston, 1990) in a large sample of adults with
moderate depression using a treatment manual.
Vromans and Schweitzer (2011) found a large pre-
to post-treatment effect size (d = 1.36) for those who
completed the NT intervention (38 out of the initial
47 clients). Moreover, a clinical significance analysis
performedwith completers according to Jacobson and
Truax’s (1991) criteria indicated that 74% of the
participants improved reliably, 61% moved to the
functional population range, and 53% recovered. It
was also found that NT completers showed significant
improvements on ameasure of interpersonal difficult-
ies. Intention-to-treat (ITT) analysis obtained a large
pre-post effect size (d = 1.10) that was comparable to
other treatments. Although this study had methodo-
logical strengths, such as the use of a structured
interview for diagnostic assessment at pre-treatment,
assessment of clinically significant change, and follow-
up assessment at 3 months, it lacked a comparison
group.
Because establishing a waiting list control group or
administering a placebo in clinical trials is often
ethically controversial, Chambless and Hollon
(1998) suggested comparison with an empirically
supported intervention for the same population.
Cognitive-Behavioral Therapy for depression
(CBT; Beck, Rush, Shaw, & Emery, 1979) is a
strong candidate for a comparison group in the
treatment of depression. It has received consistent
empirical support since the first study in the 1970s
(Rush, Beck, Kovacs, & Hollon, 1977), and it
remains one of the best-known psychological treat-
ments for depression (Butler, Chapman, Forman, &
Beck, 2006; Cuijpers, van Straten, Andersson, & van
Oppen, 2008; DeRubeis & Crits-Christoph, 1998;
Dobson, 1989; Gloaguen, Cottraux, Cucherat, &
Blackburn, 1998).
The present study aims to test the efficacy of NT
in a comparative controlled trial with CBT as the
comparison group and a primary focus on the
reduction of depressive symptoms. The secondary
aim of this study is to assess the reduction of general
psychological distress. Thus, the specific research
questions were (1) whether NT is as efficacious as
CBT in reducing depressive symptoms in adults;
(2) whether clients in the two treatments experience
changes at different rates; and (3) whether the
dropout rates differ significantly between the two
treatments. It was expected that NT outcomes
would be comparable to CBT.
Methods
Participants
Clients. Eligibility criteria were (a) having a
diagnosis of Major Depressive Disorder according
to the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV; American Psychiatric Associ-
ation, 2000), (b) being over 18 years old, (c)
agreeing to sign an informed consent to treatment,
and (d) agreeing to the videotaping of sessions and
the completion of research questionnaires. Partici-
pants were excluded if they presented (a) any Axis II
diagnosis, (b) any other concurrent Axis I disorder
that might be a focus of clinical attention (substance-
related disorders, sexual disorders, eating disorders),
(c) severe suicidal ideation, (d) psychotic symptoms,
or (e) bipolar disorder. Clients with anxiety com-
plaints or a secondary anxiety disorder were not
excluded if the anxiety was not considered a primary
complaint (e.g., panic disorder).
The trial was conducted at a psychology university
clinic in the north of Portugal that offered treatment
to both the on- and off-campus community. Poten-
tial participants were either self-referred or referred
by community mental health professionals. Therapy
was offered free of charge.
When potential participants sought consultation,
they were referred to the screening staff to determine
study eligibility. Eligible participants were assigned
by the clinic secretary to a treatment condition
according to their incoming order—one to NT, the
next to CBT, and so on. The secretary was unaware
of the specific procedures of each treatment.
The intake form was given to the therapist, who
made contact with the client for a first appointment.
The participants were unaware of the treatment
modality they would receive.
Therapists. To describe the level of clinical
experience, we used the definition proposed by
Orlinsky and Rønnestad (2005). The study included
six novice therapists (less than 1.5 years of clinical
experience), one apprentice therapist (between 1.5
and 3.5 years of clinical experience), and three
graduate therapists (between 3.5 and 7 years of
clinical experience). Two seasoned therapists
(between 15 and 25 years of clinical experience)
supervised the study’s preparation and implementa-
tion, from the elaboration of the NT manual
and adaptation of the CBT manual to training and
supervision. Some therapists delivered CBT and
others delivered NT in a nested design (i.e., they
only treated clients in one treatment manual). One
supervisor was responsible for the NT group (second
author), and the other supervisor was responsible for
the CBT group (sixth author). Both had advanced
2 R. T. Lopes et al.
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specialized training and extensive clinical and teach-
ing experience with the psychotherapy approach they
supervised.
The three graduate therapists (years of experience
Mean = 5; SD = 0.57) treated 70.8% of the cases, the
apprentice therapist (3 years of clinical experience)
treated 3.1% of the cases, and the six novice therapists
(years of experienceMean = .33; SD = 0.52) treated
26.2% of the cases. The therapists had an average of 1.9
years of experience (SD=2.13).The proportion of cases
treated by novice therapists was significantly larger in the
CBTgroup compared to theNTgroup (χ2 (2)=13.071,
p < .002).
All of the therapists were psychologists and gradu-
ate students of the Clinical Psychology Program (six
at the master’s level and four at the PhD level) at the
time the trial took place. In Portugal, psychologists
complete a 5-year program (master’s degree),
including a 1-year clinical internship, which is the
minimum training required for supervised practice.
Reported years of experience do not include the
internship.
Therapists’ training. One of the graduate thera-
pists (first author) had previous experience conduct-
ing CBT. The other graduate therapist (fifth author)
collaborated in the development of the NT treat-
ment manual and had previous experience conduct-
ing NT. The other graduate therapist and the
apprentice therapist had both theoretical and prac-
tical training in NT before joining the project. They
all received specific training on the respective treat-
ment manuals from the seasoned therapists. The six
novice therapists had theoretical training before
joining the project, and they received specific train-
ing in the treatment manuals, which consisted of
watching videotapes of experienced NT or CBT
psychotherapists with depressed clients. They also
received close supervision by the two graduate
therapists and the two seasoned therapists.
Procedures
Measures. Structured Clinical Interview for
DSM-IV - Axis I Disorders, Clinician version
(SCID-I; First, Spitzer, Gibbons, & Williams, 2002)
and Structured Clinical Interview for DSM-IV -
Axis II Personality Disorders (SCID-II; First,
Gibbon, Spitzer, Williams, & Benjamin, 1997). The
SCID-I and SCID-II are the most frequently used
diagnostic interviews in research. Training with these
clinical interviews consisted of novice therapists watch-
ing graduate therapists perform the clinical interviews.
These graduate therapists later assisted the novice
therapists in their first interviews. The diagnostic
decision was discussed in small groups of therapists
coordinated by a graduate therapist.
The Graffar Index. Socioeconomic status (SES)
was measured with the Graffar index (Graffar,
1956), which is a short scale that takes into account
income, level of education, profession, and type of
home. It divides the population into five socio-
economic layers. The data are shown using a
continuous score ranging from 5 (highest SES) to
25 (lowest SES).
Beck Depression Inventory-II (BDI-II; Beck,
Steer, & Brown, 1996). The BDI-II is considered the
gold standard measure for all research on depression
and was the primary outcome measure in this study.
It consists of 21 self-reported items grouped into
three subscales: Cognitive symptoms, affective
symptoms, and somatic symptoms. The total score
ranges from 0 to 63. The BDI-II has been shown to
have high internal consistency (α = 0.91; Steer,
Brown, Beck, & Sanderson, 2001; and α = 0.89 in
our sample). It has been translated and validated for
the Portuguese population with data similar to the
American sample (Campos & Gonçalves, 2011;
Coelho, Martins, & Barros, 2002). Because the
Portuguese studies did not calculate the Reliable
Change Index (RCI; Jacobson & Truax, 1991),
normative data gathered from meta-analyses of
diverse samples (Seggar, Lambert, & Hansen,
2002) were used to calculate the proportion of
clinical change (RCI = 8.46; cut-off score = 14.29).
Outcome Questionnaire (OQ-45.2; Lambert
et al., 1996). The OQ-45.2 is a self-report question-
naire designed to assess clients’ progress throughout
therapy and its termination. It comprises 45 ques-
tions concerning psychological distress and interper-
sonal relations as well as the social role of the client.
Cronbach’s alpha was .93 in various clinical samples
(de Jong et al., 2007; Lambert et al., 1996), and
similar reliability was obtained in our sample (α =
0.89), which is indicative of excellent internal con-
sistency. The RCI calculated for the Portuguese
population was 15 points, and the cutoff was 62
points (Machado & Fassnacht, 2014).
Adherence and Competence Scale for
Narrative and Cognitive-Behavioral Therapy
(ACS-N-CBT; Gonçalves, Bento, Lopes, & Salgado,
2009). This scale was developed specifically for this
trial and allows the quality of the sessions to be rated
from the videotapes. It consists of five “yes or no”
questions concerning general therapeutic attitudes
(therapist’s empathy, warmth, ability to control the
time of session) and 10 “never to always” questions
Narrative Therapy vs. Cognitive-Behavioral Therapy for depression 3
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(0 to 6 Likert-type scale) concerning the frequency
with which the therapist made use of the therapeutic
techniques specific to NT and CBT in the particular
session. Raters were also asked to use a Likert scale
(from 0 to 6) to evaluate the therapists’ competence
in using each of the specific aforementioned techni-
ques. Thus, this scale yields five scores: (1) the use
of general therapeutic attitudes in the session; (2) the
frequency with which CBT techniques were used in
the session; (3) the frequency with which NT
techniques were used in the session; (4) general
psychotherapeutic competence; and (5) competence
in using specific therapeutic techniques from CBT
and/or NT. The scale developers provided training
in this scale with examples of random sessions. Care
was taken that the chosen example sessions were not
the same as the ones assigned to rating. A manual for
the ACS-N-CBT scale containing instructions for
each item of the scale and common questions was
provided to the raters as support during the rating
process.
Assessment procedures. The SCID-I and
SCID-II interviews were used in the initial assess-
ment to determine eligibility and were conducted by
therapists trained for this purpose. No inter-rater
reliability was calculated because one evaluator
conducted each interview. Questions about dia-
gnostic criteria were discussed with the supervisors.
The SCID-I (First et al., 2002) was also used to
gather demographic and clinical information about
the participants. The demographic variables assessed
were age, gender, relationship status, professional
status, and education. The clinical variables assessed
were the presence of co-morbidity, medication use at
intake, previous hospitalizations, previous suicide
attempts, and previous experiences with psychother-
apy. To assess the social, occupational, and psycho-
logical functioning of the participants, the Global
Assessment of Functioning (GAF) scale was used.
The BDI-II and OQ-45.2 were used to measure the
baseline severity of depressive symptoms and treat-
ment outcomes. BDI-II was defined as the primary
outcome measure, and OQ-45.2 was defined as the
secondary outcome measure. Questionnaires were
given to the participants before the initial session and
at every fourth session (i.e., at sessions 1, 4, 8, 12,
16, and 20). The assessment of treatment integrity
using the ACS-N-CBT was made after the trial was
completed.
Treatment conditions. Treatment in both con-
ditions consisted of 20 sessions of 1 hr each.
Sessions took place weekly from session 1 to 16
and every 2 weeks from session 17 to 20. Termina-
tion occurred at the end of the 20 sessions, as
scheduled by the treatment manual (regardless of
the clinical status of the client), or at an earlier stage
of the treatment manual that was mutually agreed
upon between the therapist and client (in cases
where the client had reached the therapeutic goals).
Narrative Therapy. NT focuses on the role of
narrative processes in the organization of experience,
knowledge, and behavior. Problems arise as autobio-
graphical narratives and are restricted to problematic
contents, which White and Epston (1990) call
“problem saturated narratives.” The therapist
engages the client in activities to “re-write” self-
narratives in a process organized around three
phases: A deconstruction phase, a reconstruction
phase, and a consolidation and termination phase
(Freedman & Combs, 1996). During the decon-
struction phase, the central goal is to understand the
problem in its context, circumstances, assumptions,
effects, and influence on the person’s life in an
attempt to separate the problem from the person
(mainly using externalization). In the reconstruction
phase, the main goal is to expand the narrative
elaboration of novelties, or experiences that fall
outside the domain of the problem-saturated narrat-
ive, gradually facilitating the emergence of an altern-
ative self-narrative. These new narrative elements,
called unique outcomes (White, 2007), are explored
and contribute to an alternative self-narrative that
redefines people’s relationship with themselves, their
history, and their significant others. In the last phase
of the protocol, referred to as the consolidation and
termination phase, the goal is to consolidate the
alternative self-narrative and to root it in the network
of socio-cultural discourses and practices.
Following previous criticism on the rigidity of
therapeutic manuals (Ablon, Levy, & Katzenstein,
2006; Beutler & Harwood, 2000; Connolly Gibbons,
2003; Kendall, Chu, Gifford, Hayes, & Nauta, 1998;
Luborsky, 1993), the NT therapeutic manual was
developed to be sensitive to each client’s progress
during treatment, adjusting specific interventions to
the idiosyncratic characteristics of the clients. For
the strategies and techniques, we refer the reader
to the original unpublished manual (Gonçalves &
Bento, 2008, upon request) and to previous work by
White (2007; White & Epston, 1990), upon which
the manual was based.
Cognitive-Behavioral Therapy. CBT treat-
ment relies on the principle that depressive symp-
toms are maintained due to a dysfunctional way of
interpreting reality. The client is therefore encour-
aged to attempt new ways of thinking about himself
or herself, the world, and/or others and to test these
newly reformulated hypotheses in reality. Because
4 R. T. Lopes et al.
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the literature about CBT for depression is vast, we
refer the reader to the original treatment manual
upon which our treatment was based (Beck et al.,
1979; Leahy & Holland, 2000).
Adherence to the manual and competence.
Therapists chose the model they wanted to use given
their prior training or preferences. Treatment integ-
rity was ensured through supervision and the assess-
ment of adherence to the therapeutic manuals from
the perspective of external judges. At the beginning
of the study, the two graduate psychotherapists
received weekly supervision with two seasoned psy-
chotherapists who had extensive experience as super-
visors. Later in the study, they helped the graduate
psychotherapists (the first and fourth authors) super-
vise the younger therapists who joined the project.
All sessions were videotaped and watched during the
supervision meetings so that the supervisors could
keep track of adherence to the manual and the
quality of the interventions. After the study was
completed, videotapes of sessions 4, 8, and 12 of
25% of the randomly selected cases were rated for
adherence to the manual by external raters. Each
rater rated one case using the ACS-N-CBT scale
(Gonçalves, Bento, et al., 2009). The raters (n = 10)
were all psychologists and experienced psychothera-
pists who were familiar with both NT and CBT
theory and practice (mean age = 32.50, SD = 8.38;
mean years of clinical experience = 7.80, SD = 5.49)
and were not involved in the trial.
Analyses
Following the Consolidated Standards of Reporting
Trials (Moher, Schulz, Altman, & CONSORT
Group, 2001), separate intent-to-treat and comple-
ter analyses were performed.
Intent-to-treat group and missing data. The
intent-to-treat (ITT) analysis included all clients
who began treatment. To address the missing data
in the case of the clients who left treatment prema-
turely, the method of carrying the last observation
forward (LOCF) was used.
Statistical analysis. Group differences. The
numbers of clients who dropped out of each treat-
ment group were compared using a chi-square test.
Other differences between groups on categorical
variables were evaluated using chi-square tests.
Independent-samples t-tests were used to test the
initial differences between the two groups on con-
tinuous variables.
Efficacy. Cohen’s d was computed to express the
effect size of the pre- to post-treatment change in
each treatment condition. An analysis of covariance
(ANCOVA) was conducted for each of the outcome
measures to test the differences between treatments
in reducing depressive symptomatology, with the last
observation as the dependent variable, the treatment
group as the independent variables, and the first
observation of the outcome variable as the covariate.
Clinical significance. To examine the variety of
individual responses to treatment conditions, clinical
significance was assessed according to Jacobson and
Truax’s (1991) criteria: (a) the change should be
reliable (that is, greater than the RCI for
the respective measure) and (b) at the end of the
treatment, clients should move from a dysfunctional
population range to a range typical of the functional
population. We also present the proportion of clients
who responded according to the Percentage
Improvement method (PI). This method defines
treatment response as a pre- to post-treatment
change greater than 50% of the client’s dysfunctional
score. Following recommendations to use the cut-off
scores generated from a meta-analysis (Hiller,
Schindler, & Lambert, 2012), for the BDI-II, we
used a normative value of 14.29 points to separate
the non-clinical and clinical population, as suggested
by Seggar et al. (2002). For example, if a client
scored 30 at pre-treatment, the number of points to
be considered 100% of the change was above 14.29,
or 15.71 points. Because 50% of 15.71 is 7.88, any
change greater than this value was considered a
response for this particular client.
Rate of change. A Hierarchical Linear Model
(HLM) analysis was used to assess whether the two
treatments, NT and CBT, differed in the pace of
symptom reduction over time. The analysis was
conducted separately for the BDI-II and the OQ-
45.2 scores. All measurements for each subject were
used regardless of whether the participants com-
pleted treatment or were considered dropouts. At
level 1, the within-subject level, we modeled the
individual slope and intercept of the outcome mea-
sures for each participant over time (reflecting each
individual’s starting point and rate of change on
either the BDI-II or the OQ-45.2). At level 2, the
between-subject level, the aforementioned particip-
ant-specific parameters (slope and intercept) were
modeled using only the group assignment to test
whether differences in the rate of change could be
predicted by it.
Narrative Therapy vs. Cognitive-Behavioral Therapy for depression 5
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Results
Preliminary Analyses
Participants’ flow. During the two and a half
years it took to complete the trial (from February
2008 to October 2010), 107 people were assessed for
eligibility, 26 of whom did not meet the inclusion
criteria (see Figure 1). Of the 81 subjects who were
assigned to treatments, 16 refused to participate in
the study or did not return after the initial assess-
ment, and two were excluded for Axis-II co-
morbidity detected during treatment. These clients
were referred to more adequate treatment in the
clinic. Of the remaining 63 clients, 34 were allocated
to NT and 29 to CBT. Of the 34 participants who
received NT, 14 dropped out. Of the 29 participants
who received CBT, nine dropped out.
Comparison between participants at
baseline. Baseline demographic variables and clin-
ical characteristics for the participants of each treat-
ment condition are presented in Table I according to
the CONSORT statement guidelines (Moher et al.,
2001). No meaningful differences were found
between the participants in the two treatment con-
ditions. As shown in Table I, the participants did not
differ significantly on any of the demographic vari-
ables at the time of intake except for the number of
years of education (NTMean = 14.41, SD = 4.07;
CBTMean = 12.03, SD = 5.11; t(61) = 2.05,
p < .044). There was also no major group difference
(Table I) in any of the clinical variables (global
functioning, presence of co-morbidity, intake of
medication, previous hospitalizations, previous sui-
cide attempts, and previous experiences with psy-
chotherapy). GAF (DSM-IV; American Psychiatric
Association, 2000) was approximately 60 (NTMean =
58.94, SD = 10.87; CBTMean = 60.90, SD = 10.06;
t(61) = −.73, p = .465), which corresponds to
moderate symptoms and moderate impact on social
or occupational functioning. Still regarding initial
severity, neither on the BDI-II (NTMean = 29.08, SD
= 9.62; CBTMean = 33.89, SD = 11.46; t(61) =
!1.80, p = .075) nor on the OQ-45.2 (NTMean =
92.14, SD = 15.55; CBTMean = 97.03, SD = 22.51;
t(61) =−.73, p = .31) were differences found. Most
clients had no co-morbid anxiety disorder (NT =
85.3%; CBT = 72.4%, χ2 (1) = 1.58, p = .20) and
had never been hospitalized (NT = 94.1%; CBT =
82.8%, χ2 (1) = 2.04, p = .15). In both treatments, a
considerable number of clients were taking medica-
tion at the beginning of treatment (NT = 64.7%;
CBT = 55.2%, χ2 (1) = 0.59, p = .44). Several
clients had previous suicide attempts (NT = 11.8%;
CBT = 20.7%, χ2 (1) = 0.93, p = .33), and a few had
previous experiences with psychotherapy (NT =
11.8%; CBT = 13.8%, χ2 (1) = 0.06, p = .81).
Number of sessions in each treatment. Of
the 40 completers, 24 clients received 20 sessions
of treatment, and 16 clients completed treatment
between the eighth and 19th sessions. NT
clients, including dropouts, received an average of
12.94 sessions (SD = 7.05), whereas CBT clients
received an average of 14.90 sessions (SD = 6.48).
This difference was not statistically significant
Figure 1. CONSORT ﬂow chart in the clinical trial.
Note. NT = Narrative Therapy; CBT = Cognitive-Behavioral Therapy; ITT = Intend-to-treat.
6 R. T. Lopes et al.
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(t (61) =−1.13, p = .278). Termination occurred
either at the end of the treatment manual
(20 sessions, n = 24) or at a time that was mutually
agreed between the therapist and the client at an
earlier stage of the treatment manual (ranging from
eight to 19 sessions, n = 16).
Adherence and competence assessment.
External raters (n = 16) watched videotapes of
sessions 4, 8 and 12 of 25% of the cases (n = 16)
and rated the sessions using the ACS-N-CBT
(Gonçalves, Bento, et al., 2009). As expected, in
the NT treatment condition, therapists used signifi-
cantly more NT techniques than in the CBT treat-
ment condition (U = 0.500, p < .001). Comparably,
in the CBT treatment condition, CBT therapists
used significantly more CBT techniques than in the
NT treatment condition (U = 0.00, p < .001). The
use of general therapeutic attitudes did not differ
across treatments (U = 264, p = .307). General and
specific competence rated by external observers did
not differ between the two treatments (U = 257.5,
p = .692 and U = 206, p = .136, respectively).
Influence of medication on outcome. To
determine whether the improvement of clients taking
medication differed on the BDI-II compared to
clients not taking medication, we used an
ANCOVA. The initial BDI-II score was used as
the covariate, the final BDI-II score was the depend-
ent variable, and medication at intake was an
independent variable. There was no significant effect
of medication at intake on the BDI-II (F(1,60) =
0.14, p = .71). A similar analysis conducted with the
OQ-45.2 also revealed no significant effect for
medication at intake (F(1,60) = 1.21, p = .28).
Influence of therapist’s experience on
outcome. Because the number of clients seen by
novice therapists in CBT was significantly higher
than the number of clients seen by novice therapists
in NT, we tested the effects of the therapist’s
experience (novice, apprentice, or graduate) on the
final score on the BDI-II using an ANCOVA, with
the initial BDI-II score as the covariate. No signific-
ant effect was found for therapist experience on the
outcome (F(2,59) = 0.78, p = .463).
Table I. Clinical and demographic characteristics of the sample at baseline, according to treatment condition.
NT (n = 34) CBT (n = 29)
Variable M (SD) n (%) M (SD) n (%) t (61) χ2 (1)
Age 37.18 (12.72) 33.41 (9.72) 1.30
Gender Female 27 (79) 24 (82.8) 0.11
Male 7 (21) 5 (17.2)
Education (in years) 14.41 (4.07) 12.03 (5.11) −2.05*
SES (Graffar1) 12.25 (2.75) 12.61 (3.75) 0.54
Relationship Single 15 (44.1) 12 (41.4)
Status Married 10 (29.4) 11 (37.9) 2.07
Divorced 7 (20.6) 6 (20.7)
Widowed 2 (5.9) 0 (0)
Professional Employed 14 (41.2) 18 (62.1)
Status Unemployed 10 (29.4) 4 (13.8) 4.8
Student 8 (23.5) 7 (24.1)
Retired 2 (5.9) 0 (0)
GAF at intake 58.94 (10.87) 60.90 (10.06) −.73
Score BDI-II Session 01 29.08 (9.62) 33.89 (11.4) −1.80†
Score OQ.45.2 Session 01 92.14 (15.5) 97.03 (22.5) −1.01
Co-morbidity at intake No 29 (85.3) 21 (72.4)
(anxiety problems) Yes 5 (14.7) 8 (27.6) 1.58
Psychiatric medication at intake No 12 (35.3) 13 (44.8)
Yes 22 (64.7) 16 (55.2) 0.59
Previous hospitalizations No 32 (94.1) 24 (82.8)
Yes 2 (5.9) 5 (17.2) 2.04
Previous suicide attempts No 30 (88.2) 23 (79.3)
Yes 4 (11.8) 6 (20.7) 0.93
Previous experiences with No 30 (88.2) 25 (86.2)
psychotherapy Yes 4 (11.8) 4 (13.8) 0.06
1 Graffar is an international classification for socioeconomic status (Graffar, 1956). The higher the score is, the lower the SES. This sample
means (NT M = 12.2; CBT M = 12.6) indicate high SES.
Note. SES = socioeconomic status; GAF = Global Assessment of Functioning of the DSM-IV (First et al., 2002); BDI-II = Beck
Depression Inventory II; OQ-45.2 = Outcome Questionnaire 45.2
* Indicates statistical significance at p < .05; † indicates marginally significant difference at p < .10.
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Symptom reduction during treatment
Pre- to post-treatment means, standard deviations,
and effect sizes for both treatment groups are
presented in Table II. CBT had higher pre- to
post-treatment effect sizes when compared to NT
on the BDI-II, both for ITT (d = 1.25 for CBT and
d = 0.56 for NT) and completer (d = 1.51 for CBT
and d = 0.89 for NT) analysis. For OQ-45.2, CBT
and NT pre- to post-treatment effect sizes were very
similar (ITT analysis: d = 0.65 for CBT and d = 0.69
for NT; completer analysis: d = 0.91 for CBT and
d = 0.84 for NT).
ANCOVAs comparing the observed post-treat-
ment change with the pre-treatment scores as cov-
ariates suggest that both treatment groups showed
significant improvement in all measures for both the
ITT (n = 63) and the completer (n = 40) analyses.
Comparing CBT and NT, a significant group effect
was found for the BDI-II (F(1,60) = 4.16, p = .046)
and its somatic dimension (F(1,60) = 4.04,
p = .049), but only for the entire ITT sample. No
significant group effects for the BDI-II were found
for the completer analysis. Additionally, no signific-
ant group differences were found for the OQ-45.2
for the ITT analysis (F(1,60) = 0.15, p = .70) or the
completer analysis (F(1,37) = 0.04, p = .83). More-
over, separate ANCOVAs were conducted for each
of the three subscales of the OQ-45.2, and no
difference in the amount of change was found
between any groups (for Symptom Distress,
F(1,60) = 0.017, p = .90; for Interpersonal Related-
ness, F(1,60) = 0.78, p = .38; and for Social Role
Functioning, F(1,60) = 0.073, p = .79).
Clinical significance. Each client’s post-treat-
ment score was examined to determine (a) whether
it reliably changed, (b) whether it fell below the
cutoff scores for the functional distributions (Func-
tional Population, also referred to as remission;
Hiller et al., 2012), (c) whether it moved to the
functional distribution and improved reliably at the
same time (Clinical Significant Change), (d) whether
the final score increased more than the RCI for the
specific measure (i.e., whether individuals reliably
deteriorated during treatment), and (e) whether it
decreased by more than 50% of its value on the
dysfunctional range of the scale (i.e., whether clients
responded). Table III shows the results for the ITT
and completer analysis separately.
In the completer analysis, the group proportions
on the BDI-II were very similar on all of the
categories of clinical change (i.e., the proportion of
clients who attained reliable improvement (CBT =
75%, NT = 50%; χ2 (1) = 2.667, p = .102), who
moved to the functional population (CBT = 50%,
NT = 45%; χ2 (1) = 0.1, p = .751), or who attained
clinically significant change (CBT = 50%, NT =
40%; χ2 (1) = 0.404, p = .525)). However, in the
ITT analysis, the proportion of clients that improved
reliably was marginally larger for the CBT group
(CBT = 62.1%, NT = 38.2%; χ2 (1) = 3.55,
p = .059). The proportion of responders (according
to the PI method) was significantly larger in the CBT
group (CBT = 68.9%, NT = 41.2%; χ2 (1) = 4.865,
p = .027).
Rate of change across treatment conditions.
The results from the HLM comparing the rates of
change in the two groups indicate that according to
the BDI-II, group allocation was not significantly
related to individual growth rates (coefficient of
BDI-II for group: b = 0.283, t(62) = 1.442,
p = 0.154). This was also the case using the OQ-
45.2 (coefficient of OQ-45.2 for group: b = 0.163,
Table II. Intent-to-treat and completer analysis pre- and post-treatment mean scores, standard deviations, and effect sizes for NT and CBT.
Treatment condition
NT (n = 34) CBT (n = 29)
Measure Pre Mean (SD) Post Mean (SD) d1 (CI) Pre Post d (CI)
Intent-to-treat (LOFC, N = 63)
BDI-II 29.09 (10) 22.59 (13) 0.56 (0.08–1.05) 33.90 (11) 18.90 (13) 1.25 (0.68–1.81)
OQ-45.2 92 (16) 75.91 (29.1) 0.69 (.2–1.17) 97 (23) 79.10 (31.3) 0.65 (0.12–1.18)
Completer (n = 40)
NT (n = 20) CBT (n = 20)
BDI-II 29.4 (10.4) 18.8 (13.2) 0.89 (0.24–1.54) 33.5 (9.9) 16.4 (12.6) 1.51 (0.81–2.21)
OQ-45.2 (4) 94 (17) (5) 71.8 (33.1) 0.84 (0.20–1.49) 97.7 (23.2) 72.2 (32.4) 0.91 (0.26–1.56)
Note. NT = Narrative Therapy; CBT = Cognitive-Behavioral Therapy; BDI-II = Beck Depression Inventory-II; OQ-45.2 = Outcome
Questionnaire 45.2; SD = standard deviation; LOFC = last observation carried forward; CI = Confidence interval.
1 Effect sizes refer to pre- and post-treatment and are categorized along a continuum of “no effect” (ES < 0.2), “small effect” (0.2 ≤ ES ≤
0.5), “medium effect” (0.5 ≤ ES ≤ 0.8), and “large effect” (ES ≥ 0.8) (Cohen, 1988).
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t(62) = 0.33, p = 0.742). The rate of symptom
reduction for the BDI-II was 0.84 points per session
for the CBT group and 0.56 points for the NT
group. For the OQ-45.2, the rate of symptom
reduction was 1.17 points per session for the CBT
group and 1.01 points for the NT group. Figure 2
illustrates the rate of change for both groups.
Dropout across treatment conditions. Drop-
out in our study was defined as unilateral termina-
tion by the client without the therapist’s approval or
knowledge (Richmond, 1992) and/or failure to
attend the last scheduled appointment (Hatchett,
Han, & Cooker, 2002; Hatchett & Park, 2003).
Fourteen clients (41.2%) dropped out in the NT
group compared to nine (31%) in the CBT group,
but this difference was not statistically significant
(Fisher’s exact probability = .27). The overall drop-
out rate was 36.50%.
NT and CBT dropouts did not differ on any of the
baseline demographic variables (age, gender, rela-
tionship status, professional status, years of educa-
tion, and socioeconomic status) or on clinical
baseline variables (severity of depression, presence
of co-morbidity, medication at intake, previous
hospitalizations, and previous experiences with
psychotherapy).
Discussion
The present study aimed to assess the efficacy of NT
for major depression in adults, a popular treatment
among clinicians that has very little empirical evid-
ence in its favor, compared with CBT. The results
showed that by the end of treatment, clients in both
treatment groups scored significantly lower on all
measures. Although the completer analyses yielded
no evidence indicating differential effects or the
superiority of either CBT or NT in reducing
depressive symptoms (BDI-II) or general psychoso-
cial symptoms and problems (OQ-45.2), surpris-
ingly, when the analysis included dropouts (i.e., ITT
analysis), the CBT group showed a significantly
larger decrease of depressive symptoms at post-
treatment and a significantly larger proportion of
Table III. The percentage of reliable improvement, movement to functional population, clinically significant change, and reliable
deterioration by treatment condition and outcome measure.
BDI-II OQ-45.2
Type of change NT n (%) CBT n (%) NT n (%) CBT n (%)
ITT (n = 63)
Reliable Improvementa 13 (38.2) 18 (62.1)† 12 (35.3) 14 (48.2)
Functional Population / Remissionb 11 (32.4) 12 (41.4) 10 (29.4) 8 (27.6)
Clinical Significant Changec 10 (29.4) 12 (41.4) 9 (26.5) 6 (20.7)
Reliable Deteriorationd 1 (2.9) 0 (0) 1 (2.9) 5 (17.24%)
Responsee 14 (41.2) 20 (68.9)* 14 (41.2) 14 (48.3)
Completers (n = 40)
Reliable Improvement 10 (50) 15 (75) 12 (35.3) 11 (38)
Functional Population 9 (45) 10 (50) 9 (45) 7 (35)
Clinical Significant Change 8 (40) 10 (50) 9 (45) 5 (25)
Reliable Deterioration 0 (0) 0 (0) 1 (2,9) 3 (10)
Response 11 (55) 15 (75%) 13 (65) 12 (60)
Note. BDI-II = Beck Depression Inventory-II; OQ-45.2 = Outcome Questionnaire-45.2; NT = Narrative Therapy; CBT = Cognitive
Behavioral Therapy; ITT = Intend-to-treat; † = p < .10 and * = p < .05.
a Reliable improvement = proportion of clients who attained Reliable Improvement (changed more than the Reliable Change Index: for
BDI-II = 8.46; for OQ-45.2 = 15); b Functional Population / Remission = proportion of clients who moved into the Functional Population
(below the 80th percentile; for BDI-II = 14.29; for OQ-45.2 = 62); c Clinical Significant Change = clients who simultaneously showed
reliable improvement AND moved into the Functional Population; d proportion of clients who deteriorated reliably (more than Reliable
Change Index); e Response = change greater than 50% of pre-treatment score, considering the number of points situated on the dysfunctional
range of the scale (Percent Improvement Method; Hiller et al., 2012).
session 1 session 4 session 8 session 12 session 16 session 20
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BDI-II Change
 CBT
 NT
OQ-45 Change
 CBT
 NT
Figure 2. Course of symptom reduction in both treatment
conditions on BDI-II and OQ-45.2.
Note. BDI-II = Beck Depression Inventory-II; OQ-45.2 = Out-
come Questionnaire-45.2, NT = Narrative Therapy; CBT =
Cognitive Behavioral Therapy.
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treatment responders. This difference may indicate
that dropouts in the CBT group have better gains in
reducing depressive symptoms than the NT drop-
outs. One possible clinical explanation for this
difference is the inclusion in the CBT manual of a
clear and structured behavioral activation module at
the beginning of treatment, in which therapists have
the opportunity to work exclusively on the alleviation
of depressive symptoms. In contrast, in NT, thera-
pists directly begin to intervene with a focus on the
narrative change. NT intervention may require more
cognitive resources than some depressive clients
have available at the onset of treatment. If this
hypothesis is confirmed in future studies of NT,
narrative therapists should consider ways to address
this problem, including a more supportive module at
the beginning of the treatment manual or explaining
that the client might feel that his condition is
worsening before he begins to get better, as is often
the case with antidepressant medication. Warning
the client about this effect may change the client’s
expectation of the course of treatment and thus
enhance adherence to it.
The better results on the BDI-II for the ITT
sample may not be surprising given that CBT
treatment specifically aims to reduce depressive
symptoms in the same way that the BDI-II aims to
measure depressive symptoms. Future research
should consider the use of measures focused on
narrative change (e.g., innovative moments; Gon-
çalves, Matos, & Santos, 2009; Gonçalves, Ribeiro,
Mendes, Matos, & Santos, 2011) and outcome
measures using independent raters (e.g., the Hamil-
ton-D scale; Fleck, Poirier-Littre, Guelfi, Bourdel, &
Loo, 1995) to assess whether NT produces changes
that are more consistent with its theoretical
background.
An established benchmark for the psychothera-
peutic treatment of depression outcomes (Minami,
Wampold, Serlin, Kircher, & Brown, 2007) pro-
vided parameters for the most efficacious treatments
(efficacy benchmark) and parameters for clients who
were randomly assigned to the waiting list group
control (natural history benchmark). Comparing the
natural history benchmark with the pre-post effect
size yielded in the ITT analyses (d = 0.56) we
conclude that there is insufficient evidence to sup-
port NT as an efficacious treatment for depression.
In contrast, the effect size in the completer analysis
of NT (d = 0.89) is significantly greater than the
natural history. Thus, completing NT treatment is
reliably better than no treatment. However, even for
the completers, the effect size is not large enough to
conclude that the treatment is clinically equivalent to
the most efficacious treatments in clinical trials.
Caution must be taken when comparing our results
with this benchmark given that our sample presented
higher initial severity at the BDI-II than the sample
used to calculate this benchmark (Minami et al.,
2007). Benchmarking CBT data against the values
provided by Minami et al. (2007) shows that under-
going CBT is clinically superior than no treatment
for the more conservative ITT analysis (d = 1.25)
and the less conservative completer analysis (d =
1.51). Whereas for the ITT analysis, the effect size is
not large enough to state that the CBT group was as
effective as the efficacy benchmark, for the completer
analysis it is very likely that the CBT provided in this
trial was as effective as any effective treatment.
As mentioned previously, Vromans and Schweit-
zer (2011) have recently conducted a clinical trial
with NT, the only empirical study that is directly
comparable to ours. For those who complete treat-
ment, BDI-II pre-post effect sizes are comparable to
our findings. However, the ITT pre-post effect size
comparison confirms that our sample had poorer
improvement. Future studies may clarify this issue,
especially given that Vromans and Schweitzer (2011)
used a much shorter intervention (eight sessions,
compared to 20 sessions in the current study).
The overall dropout rate was 35.5%. Considering
the estimate of the weighted mean dropout rate of
19.7% obtained by a meta-analysis including a large
number of studies (Swift & Greenberg, 2012), this is
a high dropout rate. The considerable number of
young therapists in our sample might explain this
rate. There is some evidence suggesting a relation-
ship between the level of the therapist’s experience
and dropout rates. Trainees who had not yet
obtained their degrees have higher dropout rates
(27%) than trainees who had already obtained their
degrees (17%; Swift & Greenberg, 2012). Similarly,
some evidence has shown significantly higher drop-
out rates in university clinics (Kadera, Lambert, &
Andrews, 1996; Swift, Callahan, Heath, Herbert, &
Levine, 2010).
One might argue that the fact that our sample
included clients on medication may create a bias
favoring the efficacy of the treatments. However, the
outcomes of clients taking medication and clients
not taking medication did not differ. In addition, the
proportion of medicated clients was evenly distrib-
uted across treatments, which should attenuate any
possible bias.
Strengths and Limitations
The strengths of the study included the following: (1)
the sample size, which satisfied the analysis we applied
and is comparable to most studies in the area
(Chambless & Hollon, 1998; Kazdin & Bass, 1989);
(2) the assessment of clinically significant change; (3)
10 R. T. Lopes et al.
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the presentation of the ITT and completer analyses
separately adds information on the dropouts during
treatment; (4) the use of manualized treatments favors
the principle of replicability (Chambless & Hollon,
1998); and (5) the integrity assessment indicates that
therapists followed the manual and that they did so
with some degree of competence, which increases
confidence in the results.
Following the criteria to identify ESTs (Chamb-
less & Hollon, 1998), our study used a controlled
clinical trial design to test the efficacy of NT, the
therapists followed treatment manuals, and the
characteristics of the sample were clearly specified
and thoroughly assessed. Although these character-
istics can be regarded as strengths, the question may
be raised of the generalizability of the results. The
sample included in this trial was very homogeneous
and may not be the population normally found in
clinical settings (i.e., clients with multiple co-morbid
Axis I and II conditions). This methodological
choice emphasizes the internal validity and sacrifices
the external validity of the results (Hansen, Lambert,
& Forman, 2002; Lambert & Ogles, 2004).
The current study has other limitations. The
diversity in the therapists’ level of expertise may
have been a confounding variable because many
cases were seen by novice therapists and were not
evenly distributed in both conditions (the CBT
group had significantly more clients seen by novice
therapists than the NT group). However, the impact
of this limitation on the results is unclear because the
level of therapist experience was not related to the
outcome, a finding similar to that of other research-
ers (e.g., Kadera et al., 1996). The fact that the
therapists did not see pilot cases before seeing the
actual clients for the trial may also be considered a
limitation. The nested design used in this study
(therapists were divided by treatment group)
increases the possibility of therapist effects.
Another limitation was the way the clients were
assigned to treatments. Every other patient was
assigned to either CBT or NT as they arrived in
the clinic. It is not clear how this method may
interfere with the results because (a) this method was
conducted in a systematic manner by a clinic
administrative staff member who was unaware of
the research design, and (b) there was most likely not
a specific order or pattern in which clients sought
treatment. Although this may technically be consid-
ered a quasi-random method, it is still worth noting
the possibility of bias.
Implications of the Study
As discussed, the data were not consistent enough to
ascertain the efficacy of Narrative Therapy for
moderate depression, especially due to a high num-
ber of client dropouts who did not seem to benefit
from treatment. However, when clients completed
treatment, it appears to be an effective treatment.
Thus, the main conclusion of this study is that
additional efficacy studies are needed before NT
can be recommended for the treatment of
depression.
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